An international project mapping millions of galaxies has provided a ‘tantalising’ insight into the mysteries of dark energy and could reshape our understanding of the history of the Universe, according to a leading University of Queensland astrophysicist.
he University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved vaccine considered among the best in its class.
The University of Queensland’s small molecule drug discovery facility will open its doors to researchers from across Australia for the first time thanks to a National Collaborative Research Infrastructure Strategy (NCRIS) funding injection.
A unique partnership between The University of Queensland (UQ) and Ochsner Health (Ochsner) has been extended until at least 2030 and will continue to grow the world’s physician pipeline through a transnational Doctor of Medicine (MD) program.
Queensland will become a major international hub for vaccine discovery and development with a global partnership formed in the United States today to help address the world’s critical health challenges.
Funded by the Queensland Government, Vaxxas has opened a facility in Brisbane, Australia to support the production of its high-density microarray patches.
Understanding the mysterious force behind the expanding universe is a step closer with the first tranche of data released from the Dark Energy Spectroscopic Instrument (DESI).
Following a competitive selection process, 5 outstanding initiatives have received funding totalling $47,000 in the latest UQ Global Strategy and Partnership Seed Funding Scheme.
UQ, Oxford and Princeton researchers have developed a "test" to measure if businesses are on track to meet Paris Agreement climate action goals, and so far the results are not promising.